Cancer has no borders. Neither do we.
At BeiGene, our core value is “patients first.”
The usual development process for medicines can take a long time. We aim to create high-quality, new and advanced medicines more quickly than the usual development process.
Once developed, it is not enough for these innovative medicines to simply exist. We want to make sure patients around the world can access them as well.
We work with cancer communities to learn from and provide support to patients, caregivers and families. To help us do this, as well as to raise awareness and improve lives, we:
- Communicate honestly, transparently and accurately.
- Listen with empathy to learn from and connect with patients/caregivers, wherever they are.
- Respect the healthcare provider–patient relationship.
- Empower patients through education and by providing resources to help them manage their disease.
- Respect diversity and promote inclusion among all people impacted by cancer.
- Support initiatives and programmes that help patients live fuller, more engaged lives.
- Provide opportunities for our employees to engage in cancer communities.
We also collaborate with patient advocacy groups in the UK and Ireland. This means we can:
- Understand the most important clinical needs for patients living in the UK and Ireland.
- Have discussions with the National Institute for Health and Care Excellence (NICE). NICE considers the clinical and economic impact of medicines, helping to provide patient access to the best treatments and care.
- Ensure our clinical trials teams design trials that best serve patients.
- Create materials that clearly explain clinical trials or help patients manage their disease.
- Provide patient-focussed initiatives such as patient support helplines.
Understanding patients
At BeiGene, we think about the potential impact on patients at every step of the development process. This means we consider patients in our scientific research and during the first stages of the development of medicines.
Actively involving patients and caregivers in this process helps us understand the real-life needs and challenges faced by people living with cancer. By gaining perspectives from people with lived experiences, we can design clinical trials to reflect their needs and measure outcomes that really matter.
Patient-focussed drug development and clinical trials
Clinical trials are human research studies designed to evaluate if an investigational medicine is well-tolerated and effective for patients. People who choose to participate in clinical trials play a vital role in developing new medicines. Clinical trials may help regulatory health authorities make decisions about approving medicines. Trials may also make medicines more broadly available to patients who need them.
We strive to include diverse populations in our clinical trials, with representation for age, ethnicities, genders or LGBTIQA+ identities, abilities and geographies, wherever possible. Medications don’t always work the same for everyone, so studying the results in diverse patient groups can help us develop drugs that meet the needs of more patients.
